GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Rapid Dose Therapeutics Corp (XCNQ:DOSE) » Definitions » FCF Margin %

Rapid Dose Therapeutics (XCNQ:DOSE) FCF Margin % : -287.61% (As of Nov. 2023)


View and export this data going back to 2010. Start your Free Trial

What is Rapid Dose Therapeutics FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Rapid Dose Therapeutics's Free Cash Flow for the three months ended in Nov. 2023 was C$-0.67 Mil. Rapid Dose Therapeutics's Revenue for the three months ended in Nov. 2023 was C$0.23 Mil. Therefore, Rapid Dose Therapeutics's FCF Margin % for the quarter that ended in Nov. 2023 was -287.61%.

As of today, Rapid Dose Therapeutics's current FCF Yield % is -4.04%.

The historical rank and industry rank for Rapid Dose Therapeutics's FCF Margin % or its related term are showing as below:

XCNQ:DOSE' s FCF Margin % Range Over the Past 10 Years
Min: -4213.86   Med: -194.91   Max: -103.25
Current: -103.25


During the past 13 years, the highest FCF Margin % of Rapid Dose Therapeutics was -103.25%. The lowest was -4213.86%. And the median was -194.91%.

XCNQ:DOSE's FCF Margin % is ranked better than
54.45% of 1034 companies
in the Biotechnology industry
Industry Median: -148.935 vs XCNQ:DOSE: -103.25


Rapid Dose Therapeutics FCF Margin % Historical Data

The historical data trend for Rapid Dose Therapeutics's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rapid Dose Therapeutics FCF Margin % Chart

Rapid Dose Therapeutics Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Feb19 Feb20 Feb21 Feb22 Feb23
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - -4,213.86 -216.29 -173.52 -120.33

Rapid Dose Therapeutics Quarterly Data
Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -38.89 -41.47 -55.19 -51.84 -287.61

Competitive Comparison of Rapid Dose Therapeutics's FCF Margin %

For the Biotechnology subindustry, Rapid Dose Therapeutics's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Rapid Dose Therapeutics's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Rapid Dose Therapeutics's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Rapid Dose Therapeutics's FCF Margin % falls into.



Rapid Dose Therapeutics FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Rapid Dose Therapeutics's FCF Margin for the fiscal year that ended in Feb. 2023 is calculated as

FCF Margin=Free Cash Flow (A: Feb. 2023 )/Revenue (A: Feb. 2023 )
=-0.864/0.718
=-120.33 %

Rapid Dose Therapeutics's FCF Margin for the quarter that ended in Nov. 2023 is calculated as

FCF Margin=Free Cash Flow (Q: Nov. 2023 )/Revenue (Q: Nov. 2023 )
=-0.673/0.234
=-287.61 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Rapid Dose Therapeutics FCF Margin % Related Terms

Thank you for viewing the detailed overview of Rapid Dose Therapeutics's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Rapid Dose Therapeutics (XCNQ:DOSE) Business Description

Traded in Other Exchanges
Address
1121 Walkers Line, Unit 3, Burlington, ON, CAN, L7N 2G4
Rapid Dose Therapeutics Corp is a Canadian biotechnology company revolutionizing drug delivery through innovation. The company's flagship product QuickStrip is a thin, orally dissolvable film, that can be infused with an infinite list of active ingredients (nutraceuticals, pharmaceuticals, vaccines, cannabis) that are delivered quickly into the bloodstream resulting in rapid onset of the active ingredient.

Rapid Dose Therapeutics (XCNQ:DOSE) Headlines

No Headlines